TrialThe Journal of infectious diseases2017

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.

Joanne M Langley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.